Strides Pharma Science

Market Cap (₹ Cr.)

₹12,805

52 Week High

1,675.00

Book Value

₹231

52 Week Low

482.00

PE Ratio

62.14

PB Ratio

5.64

PE for Sector

37.21

PB for Sector

3.95

ROE

-10.63 %

ROCE

6.67 %

Dividend Yield

0.18 %

EPS

₹14.07

Industry

Pharmaceuticals

Sector

Pharmaceuticals - Indian - Bulk Drugs & Formln

Investment Returns

In Long Term

In Short Term

1 Year

0.00%

2 Years

0.00%

3 Years

0.00%

4 Years

0.00%

5 Years

0.00%

Growth Rate

Revenue Growth

8.26 %

Net Income Growth

35.67 %

Cash Flow Change

1,478.63 %

ROE

32.53 %

ROCE

1,032.13 %

EBITDA Margin (Avg.)

38.94 %

Financial Results

Quarterly Financials	Mar 2015	Jun 2015	Sept 2015	Dec 2015	Mar 2016	Jun 2016	Sept 2016	Dec 2016	Mar 2017	Jun 2017	Sept 2017	Dec 2017	Mar 2018	Jun 2018	Sept 2018	Dec 2018	Mar 2019	Jun 2019	Sept 2019	Dec 2019	Mar 2020	Jun 2020	Sept 2020	Dec 2020	Mar 2021	Jun 2021	Sept 2021	Dec 2021	Mar 2022	Jun 2022	Sept 2022	Dec 2022	Mar 2023	Jun 2023	Sept 2023	Dec 2023	Mar 2024	Jun 2024	Sept 2024
Revenue	351	525	568	551	730	540	558	410	382	431	401	426	1,131	366	359	437	491	466	458	389	477	424	428	437	657	518	597	447	540	431	502	416	590	487	572	529	647	594	634
Expenses	241	455	500	445	622	453	465	378	276	371	354	292	316	322	342	384	358	395	362	338	387	381	376	368	546	501	528	436	438	484	487	341	459	420	514	460	527	520	547
EBITDA	110	70	68	106	108	88	93	31	106	60	47	134	815	43	17	53	133	71	96	51	90	43	52	70	111	17	69	11	103	-54	15	75	131	67	58	69	120	74	87
Operating Profit %	-0 %	0 %	1 %	6 %	13 %	10 %	8 %	-2 %	11 %	-1 %	2 %	17 %	19 %	8 %	-1 %	7 %	18 %	11 %	15 %	9 %	14 %	7 %	4 %	13 %	14 %	2 %	8 %	1 %	4 %	-14 %	-1 %	12 %	19 %	12 %	7 %	12 %	15 %	11 %	10 %
Depreciation	13	25	26	25	28	29	30	17	21	18	19	20	21	20	21	20	22	23	23	23	24	24	25	25	25	27	27	26	24	24	24	22	23	21	23	21	21	22	22
Interest	9	21	21	27	34	29	29	18	18	26	23	22	11	11	11	15	16	17	15	16	18	16	14	17	18	18	18	17	22	26	35	35	43	37	42	44	47	48	50
Profit Before Tax	87	24	21	54	46	30	33	-4	67	16	5	91	783	12	-16	18	95	30	58	11	48	3	13	27	69	-28	24	-32	57	-104	-44	18	65	9	-7	4	53	4	14
Tax	18	10	8	5	-16	1	-2	28	-16	0	-0	21	17	0	0	9	16	9	13	5	-12	1	3	3	13	0	0	0	-158	0	-19	-7	-23	-0	3	1	-3	1	-3
Net Profit	70	15	13	49	53	27	31	-25	75	9	13	105	761	11	-14	15	99	25	47	12	38	1	9	20	48	-21	19	-18	201	-66	-4	13	62	8	-7	3	54	2	15
EPS in ₹	11.69	1.84	1.66	4.32	5.96	3.04	3.44	-2.74	8.41	1.00	1.40	11.78	84.97	1.18	-1.60	1.71	11.04	2.76	5.25	1.30	4.21	0.10	0.98	2.29	5.36	-2.37	2.06	-1.96	22.33	-7.38	-0.44	1.39	6.91	0.89	-0.75	0.28	5.84	0.26	1.66

Show % Change

Above figures are in Rs. Crores

Balance Sheet

Balance Sheet	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total Assets	2,152	5,304	5,481	4,285	4,663	4,677	5,221	5,434	5,620	5,838
Fixed Assets	395	1,058	1,194	564	574	651	644	617	597	556
Current Assets	1,215	2,646	2,579	1,500	1,664	1,396	1,744	1,975	2,126	2,416
Capital Work in Progress	39	180	158	144	122	112	111	56	55	94
Investments	561	2,373	2,520	1,777	2,149	2,171	2,395	2,400	2,492	2,498
Other Assets	1,158	1,693	1,609	1,801	1,818	1,743	2,072	2,361	2,476	2,689
Total Liabilities	678	2,146	2,249	1,123	1,406	1,518	1,973	2,027	2,165	2,277
Current Liabilities	496	1,245	1,434	1,104	1,389	1,455	1,591	1,841	1,797	1,995
Non Current Liabilities	182	901	815	19	17	63	383	186	368	281
Total Equity	1,474	3,158	3,233	3,162	3,257	3,159	3,248	3,407	3,455	3,561
Reserve & Surplus	1,415	3,068	3,143	3,073	3,167	3,069	3,158	3,317	3,365	3,469
Share Capital	60	89	89	90	90	90	90	90	90	92

Show % Change

Above figures are in Rs. Crores

Cash Flow

Cash Flow	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Net Cash Flow	-290	592	-538	-208	-3	-3	-42	-13	70	11
Investing Activities	305	-1,062	-883	433	-166	63	-276	19	-183	-61
Operating Activities	207	83	412	66	40	138	283	-283	242	-36
Financing Activities	-802	1,571	-67	-707	123	-204	-49	251	11	108

Show % Change

Above figures are in Rs. Crores

Share Holding

% Holding	Mar 2021	Jun 2021	Sept 2021	Dec 2021	Mar 2022	Jun 2022	Sept 2022	Dec 2022	Mar 2023	Jun 2023	Sept 2023	Dec 2023	Mar 2024	Jun 2024	Sept 2024
Promoter	29.67 %	29.62 %	29.60 %	29.60 %	30.60 %	30.37 %	31.07 %	30.89 %	28.27 %	28.07 %	27.78 %	27.39 %	25.88 %	25.86 %	25.84 %
FIIs	24.82 %	25.80 %	24.96 %	19.85 %	19.66 %	21.21 %	21.38 %	18.93 %	18.80 %	16.67 %	17.20 %	19.45 %	24.57 %	26.71 %	30.08 %
DIIs	16.08 %	14.62 %	20.43 %	21.08 %	18.82 %	16.62 %	15.52 %	18.90 %	18.34 %	20.05 %	19.96 %	19.41 %	18.04 %	18.56 %	18.24 %
Government	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.01 %	0.01 %	0.01 %	0.01 %	0.01 %	0.01 %	0.01 %	0.01 %	0.01 %
Public / Retail	29.42 %	29.96 %	25.00 %	29.47 %	30.92 %	31.79 %	32.02 %	31.27 %	34.58 %	35.19 %	35.05 %	33.74 %	31.50 %	28.87 %	25.83 %

Show % Change

Dividend History

Peer Comparison Compare Peers on Screener

Competitors	LTP	Market Cap (₹ Cr.)	P/E Ratio	Revenue (₹ Cr.)	YoY Revenue Growth %	Net Profit (₹ Cr.)	YoY Profit Growth %	RSI
Sun Pharmaceutical	1,780.00	4,25,929.94	38.00	49,887.17	12.06	9,648	27.35	40.93
Cipla	1,465.50	1,18,825.56	25.74	26,520.66	14.17	4,155	12.95	37.73
Mankind Pharma	2,558.65	1,02,885.42	48.65	10,615.63	19.57	1,942	28.89	45.52
Dr Reddys Laboratories	1,195.35	1,01,290.13	18.97	28,905.40	12.36	5,578	-9.47	29.85
Zydus Life Science	944.05	95,280.30	22.27	19,831.50	13.82	3,831	14.57	31.20
Lupin	2,043.00	92,929.19	35.38	20,141.50	19.94	1,936	73.52	37.89
Aurobindo Pharma	1,220.00	73,119.28	20.05	29,559.25	17.55	3,169	8.65	18.05
Alkem Laboratories	5,604.75	66,062.65	30.38	12,978.42	9.84	1,811	14.16	40.42
Glenmark Pharmaceuticals	1,466.40	42,112.35	-	12,653.09	6.58	-1,831	675.84	28.12
IPCA Laboratories	1,573.55	39,910.21	59.43	7,829.81	22.92	529	80.05	52.22